SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-023464
Filing Date
2022-02-15
Accepted
2022-02-15 06:18:45
Documents
51
Period of Report
2022-02-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm226792d1_8k.htm   iXBRL 8-K 27947
2 EXHIBIT 99.1 tm226792d1_ex99-1.htm EX-99.1 70556
6 GRAPHIC tm226792d1_ex99-1img01.jpg GRAPHIC 127773
7 GRAPHIC tm226792d1_ex99-1img02.jpg GRAPHIC 311136
8 GRAPHIC tm226792d1_ex99-1img03.jpg GRAPHIC 121731
9 GRAPHIC tm226792d1_ex99-1img04.jpg GRAPHIC 139747
10 GRAPHIC tm226792d1_ex99-1img05.jpg GRAPHIC 137379
11 GRAPHIC tm226792d1_ex99-1img06.jpg GRAPHIC 183254
12 GRAPHIC tm226792d1_ex99-1img07.jpg GRAPHIC 180550
13 GRAPHIC tm226792d1_ex99-1img08.jpg GRAPHIC 176035
14 GRAPHIC tm226792d1_ex99-1img09.jpg GRAPHIC 262087
15 GRAPHIC tm226792d1_ex99-1img10.jpg GRAPHIC 176595
16 GRAPHIC tm226792d1_ex99-1img11.jpg GRAPHIC 139894
17 GRAPHIC tm226792d1_ex99-1img12.jpg GRAPHIC 175445
18 GRAPHIC tm226792d1_ex99-1img13.jpg GRAPHIC 126377
19 GRAPHIC tm226792d1_ex99-1img14.jpg GRAPHIC 175326
20 GRAPHIC tm226792d1_ex99-1img15.jpg GRAPHIC 174838
21 GRAPHIC tm226792d1_ex99-1img16.jpg GRAPHIC 204161
22 GRAPHIC tm226792d1_ex99-1img17.jpg GRAPHIC 149279
23 GRAPHIC tm226792d1_ex99-1img18.jpg GRAPHIC 157968
24 GRAPHIC tm226792d1_ex99-1img19.jpg GRAPHIC 260558
25 GRAPHIC tm226792d1_ex99-1img20.jpg GRAPHIC 172226
26 GRAPHIC tm226792d1_ex99-1img21.jpg GRAPHIC 136012
27 GRAPHIC tm226792d1_ex99-1img22.jpg GRAPHIC 200369
28 GRAPHIC tm226792d1_ex99-1img23.jpg GRAPHIC 130222
29 GRAPHIC tm226792d1_ex99-1img24.jpg GRAPHIC 130189
30 GRAPHIC tm226792d1_ex99-1img25.jpg GRAPHIC 138672
31 GRAPHIC tm226792d1_ex99-1img26.jpg GRAPHIC 182737
32 GRAPHIC tm226792d1_ex99-1img27.jpg GRAPHIC 169508
33 GRAPHIC tm226792d1_ex99-1img28.jpg GRAPHIC 210402
34 GRAPHIC tm226792d1_ex99-1img29.jpg GRAPHIC 149955
35 GRAPHIC tm226792d1_ex99-1img30.jpg GRAPHIC 162950
36 GRAPHIC tm226792d1_ex99-1img31.jpg GRAPHIC 152780
37 GRAPHIC tm226792d1_ex99-1img32.jpg GRAPHIC 158901
38 GRAPHIC tm226792d1_ex99-1img33.jpg GRAPHIC 193331
39 GRAPHIC tm226792d1_ex99-1img34.jpg GRAPHIC 173854
40 GRAPHIC tm226792d1_ex99-1img35.jpg GRAPHIC 167317
41 GRAPHIC tm226792d1_ex99-1img36.jpg GRAPHIC 131183
42 GRAPHIC tm226792d1_ex99-1img37.jpg GRAPHIC 141911
43 GRAPHIC tm226792d1_ex99-1img38.jpg GRAPHIC 144406
  Complete submission text file 0001104659-22-023464.txt   9151763

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aplt-20220215.xsd EX-101.SCH 3066
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aplt-20220215_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aplt-20220215_pre.xml EX-101.PRE 22617
45 EXTRACTED XBRL INSTANCE DOCUMENT tm226792d1_8k_htm.xml XML 3688
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 22636975
SIC: 2834 Pharmaceutical Preparations